Almirall S.A. Partners with Novo Nordisk to Develop Novel Dermatological Therapy

  "This new partnership builds on our innovation strategy and will allow us to explore the innovative approach of IL-21 blockage as a possible new pa...

February 20, 2024 | Tuesday | News
Sarepta's ELEVIDYS Supplement Accepted by FDA for Duchenne Treatment Expansion

ChatGPT CAMBRIDGE, Mass.--(BUSINESS WIRE)--February 16, 2024 07:00 AM Eastern Standard Time Sarepta Therapeutics, Inc. (NASDAQ:...

February 19, 2024 | Monday | News
Bayer AG and AskBio Initiate Phase II Trial of AB-1002 Gene Therapy for Congestive Heart Failure

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announ...

February 19, 2024 | Monday | News
Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan BLA Accepted in U.S. for Advanced Nonsquamous NSCLC Treatment

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have announced the acceptance of their Biologics License Application (BLA) for datopotamab...

February 19, 2024 | Monday | News
Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)

  Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved...

February 16, 2024 | Friday | News
FDA Grants Orphan-Drug Designation to Mesoblast's Revascor® for Congenital Heart Disease in Children

Mesoblast's Chief Executive, Silviu Itescu, expressed satisfaction with the FDA's decision: “We are very pleased to have now been granted both Orphan...

February 15, 2024 | Thursday | News
Roche Collaborates with PathAI to Enhance Digital Pathology Capabilities for Companion Diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

February 13, 2024 | Tuesday | News
PatenSee and Fresenius Medical Care Sign Clinical Collaboration Agreement

Under the agreement, the parties will first collaborate in a joint, multi-center, pilot trial of PatenSee's contactless monitoring system in Fresenius Medi...

February 13, 2024 | Tuesday | News
Samsung Launches Women’s Health Resource at SMFM 2024

Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound division, proudly announces the launch of the Samsung Ultrasoun...

February 09, 2024 | Friday | News
Auron Therapeutics Unveils Groundbreaking Cancer Treatment Candidate AUTX-703 from AURIGIN™ Platform

    Auron Therapeutics, a pioneering biotechnology firm dedicated to advancing targeted cancer therapies, has announced the selection of its in...

February 08, 2024 | Thursday | News
Seegene Teams Up with Microsoft for a Disease-Free World Vision

Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics'...

January 24, 2024 | Wednesday | News
DNAnexus and TMA Precision Health Collaborate to Enhance Rare Disease Diagnostics and Treatments

-DNAnexus, Inc., the provider of the Precision Health Data Cloud, and TMA Precision Health, a global health platform for rare diseases, announced a collabo...

January 24, 2024 | Wednesday | News
STARLIMS Launches Next-Gen LIMS, Life Sciences for Public Health (LPH) 1.0

Embracing the latest technology trends, LPH 1.0 represents a significant leap forward, with an upgrade to HTML5 browser-based technology. This advancement ...

January 23, 2024 | Tuesday | News
GH Research Secures European Patent for Mebufotenin in Depression Treatment

The newly granted patent, EP3927337, which will have an effective date of February 14, 2024, and an expiry date of no earlier than 2040, is expected to cov...

January 19, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close